These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28140313)

  • 1. [Guidelines for molecular monitoring of BCR-ABL1 in chronic myeloid leukemia patients by RT-qPCR].
    Larripa I; Ruiz MS; Gutiérrez M; Bianchini M
    Medicina (B Aires); 2017; 77(1):61-72. PubMed ID: 28140313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scale.
    White HE; Hedges J; Bendit I; Branford S; Colomer D; Hochhaus A; Hughes T; Kamel-Reid S; Kim DW; Modur V; Müller MC; Pagnano KB; Pane F; Radich J; Cross NC; Labourier E
    Clin Chem; 2013 Jun; 59(6):938-48. PubMed ID: 23471097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion, correction, and International Scale standardization: results From a Multicenter External Quality Assessment Study for BCR-ABL1 testing.
    Griffiths M; Patton SJ; Grossi A; Clark J; Paz MF; Labourier E;
    Arch Pathol Lab Med; 2015 Apr; 139(4):522-9. PubMed ID: 25061833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of droplet digital polymerase chain reaction for measuring BCR-ABL1 in chronic myeloid leukaemia in an international interlaboratory study.
    Scott S; Cartwright A; Francis S; Whitby L; Sanzone AP; Mulder A; Galimberti S; Dulucq S; Mauté C; Lauricella C; Salmon M; Rose S; Willoughby J; Boeckx N; Pallisgaard N; Maier J; Leibundgut EO; Zizkova H; Ling Goh L; Duong C; Tang WF; Ma E; Shivakumar Y; Beppu L; Bhagavatula P; Chantry A
    Br J Haematol; 2021 Jul; 194(1):53-60. PubMed ID: 34114218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a novel multiplex RT-qPCR assay for the quantification of leukemia-associated BCR-ABL1 translocation.
    Kottwitz D; El Hadi H; El Amrani M; Cabezas S; Dehbi H; Nadifi S; Quessar A; Colomer D; Moumen A; Sefrioui EL
    Int J Hematol; 2015 Sep; 102(3):335-41. PubMed ID: 26243622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network.
    Schäfer V; White HE; Gerrard G; Möbius S; Saussele S; Franke GN; Mahon FX; Talmaci R; Colomer D; Soverini S; Machova Polakova K; Cross NCP; Hochhaus A; Ernst T
    J Cancer Res Clin Oncol; 2021 Oct; 147(10):3081-3089. PubMed ID: 33677711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the challenge in measuring and standardizing BCR-ABL1.
    Yu S; Cui M; He X; Jing R; Wang H
    Clin Chem Lab Med; 2017 Aug; 55(10):1465-1473. PubMed ID: 28222016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCR-ABL1 RT-qPCR for monitoring the molecular response to tyrosine kinase inhibitors in chronic myeloid leukemia.
    Press RD; Kamel-Reid S; Ang D
    J Mol Diagn; 2013 Sep; 15(5):565-76. PubMed ID: 23810242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular monitoring of chronic myeloid leukemia: international standardization of BCR-ABL1 quantitation.
    Zhen C; Wang YL
    J Mol Diagn; 2013 Sep; 15(5):556-64. PubMed ID: 23876601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RT-qPCR and RT-Digital PCR: A Comparison of Different Platforms for the Evaluation of Residual Disease in Chronic Myeloid Leukemia.
    Alikian M; Whale AS; Akiki S; Piechocki K; Torrado C; Myint T; Cowen S; Griffiths M; Reid AG; Apperley J; White H; Huggett JF; Foroni L
    Clin Chem; 2017 Feb; 63(2):525-531. PubMed ID: 27979961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of major BCR-ABL1 mRNA by digital polymerase chain reaction is useful for prediction of international scale.
    Furuya D; Moriai M; Koizumi Y; Endo T; Asanuma K; Yanagihara N; Takahashi S
    Int J Clin Oncol; 2019 Jul; 24(7):871-875. PubMed ID: 30798394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative BCR-ABL1 RQ-PCR fusion transcript monitoring in chronic myelogenous leukemia.
    Moore FR; Rempfer CB; Press RD
    Methods Mol Biol; 2013; 999():1-23. PubMed ID: 23666687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programme for Harmonization to the International Scale in Latin America for BCR-ABL1 quantification in CML patients: findings and recommendations.
    Ruiz MS; Sánchez MB; Vera Contreras YM; Agrielo E; Alonso M; Altuna ME; Anchordoqui MS; Asinari M; Bonetto ME; Camargo M; Giere I; González J; Granda Alacote AC; Guerra J; Gutiérrez M; Maldonado C; Makiya R; Manrique G; Monaco ME; Rozo JC; Santamaría C; Seravalle A; Zea O; Zubillaga MN; Mordoh J; Larripa I; Bianchini M
    Clin Chem Lab Med; 2020 Nov; 58(12):2025-2035. PubMed ID: 32374276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardization.
    Cross NC; Hochhaus A; Müller MC
    Ann Hematol; 2015 Apr; 94 Suppl 2():S219-25. PubMed ID: 25814088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK.
    Cross NCP; White HE; Evans PAS; Hancock J; Copland M; Milojkovic D; Mason J; Craine S; Mead AJ
    Br J Haematol; 2018 Sep; 182(6):777-788. PubMed ID: 30125955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International reporting scale of BCR-ABL1 fusion transcript in chronic myeloid leukemia: first report from India.
    Balasubramanian P; Chendamarai E; Markose P; Fletcher L; Branford S; George B; Mathews V; Chandy M; Srivastava A
    Acta Haematol; 2012; 127(3):135-42. PubMed ID: 22249155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia.
    Foroni L; Wilson G; Gerrard G; Mason J; Grimwade D; White HE; de Castro DG; Austin S; Awan A; Burt E; Clench T; Farruggia J; Hancock J; Irvine AE; Kizilors A; Langabeer S; Milner BJ; Nickless G; Schuh A; Sproul A; Wang L; Wickham C; Cross NC
    Br J Haematol; 2011 Apr; 153(2):179-90. PubMed ID: 21382019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction for sustained deep molecular response of BCR-ABL1 levels in patients with chronic myeloid leukemia in chronic phase.
    Sasaki K; Kantarjian H; O'Brien S; Ravandi F; Konopleva M; Borthakur G; Garcia-Manero G; Wierda W; Daver N; Ferrajoli A; Takahashi K; Jain P; Rios MB; Pierce S; Jabbour E; Cortes JE
    Cancer; 2018 Mar; 124(6):1160-1168. PubMed ID: 29266206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a novel variant BCR-ABL1 fusion transcript in a patient with chronic myeloid leukemia: Implications for molecular monitoring.
    Crampe M; Haslam K; Kelly J; Conneally E; Langabeer SE
    Hematol Oncol Stem Cell Ther; 2017 Jun; 10(2):85-88. PubMed ID: 27013275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cartridge-based automated BCR-ABL1 mRNA quantification: solving the issues of standardization, at what cost?
    Cayuela JM; Macintyre E; Darlington M; Abdelali RB; Fund X; Villarese P; Tulliez M; Raffoux E; Sigaux F; Réa D; Seror V
    Haematologica; 2011 May; 96(5):664-71. PubMed ID: 21330326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.